Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukemic iritis with hypopyon.

R L Gruenewald, M C Perry, P H Henry

    Cancer
    |October 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Leukemic relapse can manifest as eye inflammation, specifically iritis with malignant hypopyon, even after central nervous system (CNS) sanctuary treatment. Regular eye exams are crucial for early detection in leukemia patients with ocular symptoms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The impact of cervical cytobrush sampling on cervico-vaginal immune parameters and microbiota relevant to HIV susceptibility.

    Scientific reports·2020
    Same author

    Differential effect of age on survival in advanced NSCLC in women versus men: analysis of recent Eastern Cooperative Oncology Group (ECOG) studies, with and without bevacizumab.

    Lung cancer (Amsterdam, Netherlands)·2012
    Same author

    Gemcitabine and pemetrexed administered in rapid sequence as front-line chemotherapy for advanced non-small-cell lung cancer: a phase II clinical trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009
    Same author

    Number of repetitions to maximum in hop tests in patients with anterior cruciate ligament injury.

    International journal of sports medicine·2005
    Same author

    Selective rhenium-catalyzed oxidation of secondary alcohols with methyl sulfoxide in the presence of ethylene glycol, a convenient one-pot synthesis of ketals.

    Organic letters·2005
    Same author

    Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity.

    Annals of oncology : official journal of the European Society for Medical Oncology·2004
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    Same journal

    Most older patients with advanced cancer prioritize QOL over extending survival: A secondary analysis of the GAP70+ trial found that among adults aged 70 and older with advanced, noncurable cancer, nearly three-quarters prioritized maintaining QOL.

    Cancer·2026
    Same journal

    Real-world safety, prognostic, and design considerations in ketogenic diet trials for pancreatic cancer.

    Cancer·2026
    See all related articles

    Area of Science:

    • Ophthalmology
    • Hematology
    • Oncology

    Background:

    • Acute lymphoblastic leukemia (ALL) patients often receive prophylactic treatment targeting the central nervous system (CNS) to prevent relapse.
    • Treatments include cranial X-irradiation and intrathecal methotrexate, aiming for CNS sanctuary.
    • Despite preventative measures, relapse can occur, sometimes with unusual initial presentations.

    Observation:

    • A patient with a history of ALL, treated for CNS sanctuary, presented with iritis and malignant hypopyon.
    • This ocular manifestation was the first clinical sign of disease relapse.
    • The patient received treatment with corticosteroids and local X-irradiation for the ocular condition.

    Findings:

    • Leukemic infiltration of the iris can be an initial indicator of relapse in acute lymphoblastic leukemia.

    Related Experiment Videos

  • Ocular symptoms in leukemia patients warrant thorough investigation, including slit-lamp examination.
  • Malignant hypopyon, a rare presentation, signifies aggressive disease recurrence.

    • Implications:

    • Ophthalmologists and oncologists should consider leukemic relapse in patients presenting with unexplained iritis and hypopyon.
    • Routine ophthalmological screening, particularly slit-lamp examination, is vital for early detection of relapse in ALL patients with eye complaints.
    • Prompt diagnosis and management of ocular leukemia can potentially improve patient outcomes and guide systemic therapy adjustments.